Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

4.19
Delayed Data
As of May 27
 +0.11 / +2.70%
Today’s Change
3.11
Today|||52-Week Range
8.10
-24.78%
Year-to-Date
No recent news for Cytosorbents Corp.

Today’s Trading

Previous close4.08
Today’s open4.10
Day’s range4.04 - 4.19
Volume42,570
Average volume (3 months)73,484
Market cap$106.7M
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+74.42%
Earnings growth (this year)-6.82%
Earnings growth (next 5 years)--
Revenue growth (last year)+16.22%
P/E ratioNM
Price/Sales28.93
Price/Book12.99

Competitors

 Today’s
change
Today’s
% change
PAVMUPAVmed Inc-0.15-1.33%
MTPMidatech Pharma PLC-0.05-1.30%
IBIOIbio Inc-0.02-2.55%
CDTXCidara Therapeutics ...+0.02+0.18%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$4.8M
Annual profit (last year)-$8.1M
Net profit margin-169.71%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Phillip P. Chan
Chief Operating Officer
Vincent Capponi
Corporate headquarters
Monmouth Junction, New Jersey

Forecasts

Partner Offers

Search for Jobs